Screener

Eligibility screening

A Phase I/II Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849

Sponsored by 1ST Biotherapeutics, Inc.Study detailsClinicalTrials.gov

5 US sites in OH, TX, VA, WA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.